iHuman Inc. American depositary shares, each representing five Class A ordinary shares (IH) is a publicly traded Consumer Defensive sector company. As of September 29, 2026, IH trades at $1.17 with a market cap of $58.78M and a P/E ratio of 0.00. IH moved +1.74% today. Year to date, IH is -45.25%; over the trailing twelve months it is -58.71%. Its 52-week range spans $1.11 to $3.60. Rallies surfaces IH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Chinese edtech firm iHuman Q2 revenue falls amid lower demand: iHuman’s second-quarter 2026 revenue fell 18% year over year to RMB 173.4 million, and it reported a net loss versus net income a year earlier. Gross margin was 64.1%, while operating expenses rose to RMB 132 million.
| Metric | Value |
|---|---|
| Price | $1.17 |
| Market Cap | $58.78M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.10% |
| 52-Week High | $3.60 |
| 52-Week Low | $1.11 |
| Volume | 412 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IH analyst coverage data. Average price target: $0.00.